BPC-157 10mg

BPC-157 Peptide

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide composed of 15 amino acids. It is a partial sequence of the body protection compound (BPC) that is discovered in and isolated from human gastric juice. Structurally, it is defined by the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.

Unlike many regulatory peptides that require complex delivery systems, BPC-157 is known for its high stability. It remains stable in human gastric juice for extended periods, a characteristic that has led researchers to investigate both its systemic and localized regenerative properties. It is engineered to mimic the body’s natural cytoprotective mechanisms, particularly within the gastrointestinal tract and the musculoskeletal system.

Overview

BPC-157 is a subject of significant interest in regenerative medicine due to its multifaceted biological activity. It is often categorized as a “stable gastric pentadecapeptide” because of its ability to withstand enzymatic degradation. Its primary mechanism of action is thought to involve the modulation of the nitric oxide (NO) system, the activation of the EGR-1 gene, and the stimulation of various growth factor pathways, such as vascular endothelial growth factor (VEGF).

The peptide’s “cytoprotective” profile suggests it works to maintain mucosal integrity and accelerate the repair of damaged tissues. Researchers are currently evaluating its potential to bridge the gap in healing processes for tissues with low vascularity, such as tendons and ligaments, while simultaneously investigating its neuroprotective and cardioprotective effects in animal models.

Chemical Makeup

• Molecular Formula: C62​H98​N16​O22​
• Molecular Weight: 1419.5 g/mol
• Other Known Titles: Bepecin, PL 14736, Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

---

Research Studies and Clinical Trials

BPC-157 and Soft Tissue Healing

In numerous preclinical studies, BPC-157 has demonstrated a consistent ability to accelerate the healing of transected tendons and torn ligaments. Researchers have observed that the peptide promotes the outgrowth of tendon fibroblasts and increases the expression of growth factor receptors. One study noted that BPC-157 improved the healing of the Achilles tendon in rats, resulting in better functional recovery and increased collagen fiber density compared to control groups.

Gastrointestinal Cytoprotection and Inflammatory Bowel Disease (IBD)

Extensive research has focused on BPC-157’s role in the gut-brain axis and gastrointestinal health. In models of inflammatory bowel disease (IBD), the peptide has been shown to reduce mucosal inflammation and promote the healing of gastric ulcers. Its mechanism involves the stabilization of the “gut-blood barrier,” preventing the translocation of toxins. Studies suggest that by modulating the NO system, BPC-157 can balance angiogenesis and blood flow to damaged tissue without promoting the uncontrolled cell growth often associated with other growth factors.

Angiogenesis and Nitric Oxide Modulation

A key area of investigation is BPC-157’s interaction with vascular systems. Research indicates that the peptide acts as an angiogenic agent, meaning it helps in the formation of new blood vessels. This is particularly evident in studies where BPC-157 helped bypass occluded blood vessels through the creation of collateral pathways. This effect is believed to be mediated through the stimulation of the VEGFR2 signaling pathway, which is critical for vascular repair and recovery from ischemic injury.

Neuroprotective and Anti-inflammatory Observations

Recent pilot studies have explored BPC-157’s potential impact on the central nervous system. Observations suggest that the peptide may help counteract the damaging effects of certain neurotoxins and reduce neuroinflammation. Additionally, in models of systemic inflammation, BPC-157 has been noted to interact with the dopaminergic and serotonergic systems, leading researchers to hypothesize potential future applications in addressing mood disorders and neurological recovery.

---

Disclaimer: BPC-157 is a research chemical and is not currently approved by the FDA or EMA for human use. This description is for informational purposes based on current research data and does not constitute medical advice. BPC-157 is available for research and laboratory purposes only.